The Role of the 21-Gene Recurrence Score in Breast Cancer Treatment

Abstract

Several multi-gene assays have been developed to predict the risk of recurrence in patients with estrogen receptor-positive early breast cancer and in whom endocrine therapy is planned. The 21-gene assay is widely used and its prognostic value has been retrospectively validated, showing significant differences in the risk of distant recurrence for patients… (More)
DOI: 10.1007/s40291-016-0209-0

2 Figures and Tables

Topics

  • Presentations referencing similar topics